Total Funding
25
22
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
224063
Vyant Bio is laboratory that develops and commercializes proprietary genomic tests and services to empower cancer treatment.
Joanna C. Horobin: Non Executive DirectorPast Role: Verastem Oncology, Chief Medical Officer- Raju S.K. Chaganti: Founder
About the Company
Vyant Bio, Inc. (“Vyant Bio” or “Company”) operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company is executing on the integration of these two leading businesses to integrate human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and
development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.
